Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
  • 1
    Book
    Book
    New York, NY :Oxford University Press,
    UID:
    almafu_BV021840899
    Format: XIV, 336 Seiten : , Illustrationen.
    Edition: 2. edition
    ISBN: 0-19-530095-5 , 978-0-19-530095-6
    Note: Includes bibliographical references and index
    Language: English
    Subjects: Economics , Law
    RVK:
    RVK:
    Keywords: Pharmazeutische Industrie ; Strukturwandel ; Pharmazeutische Industrie ; Arzneimittelmarkt ; Gesundheitspolitik ; Pharmazeutische Industrie ; Gesundheitspolitik ; Internationaler Vergleich
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 2
    Online Resource
    Online Resource
    Oxford : Oxford University Press, USA
    UID:
    gbv_723630712
    Format: Online-Ressource (351 p.)
    ISBN: 9780195300956
    Content: The pharmaceutical industry is praised as a world leader in high technology innovation and the creator of products that increase both longevity and quality of life for people throughout the world. At the same time, the industry is also criticized for its marketing and pricing practices and for its apparent anticompetitive responses to generic competition. Even its research and development priorities are criticized as being too closely driven by the goal of maximizing shareholder value, rather than the health of the public. Unfortunately, many of the critics of the industry fail to understand t
    Note: Description based upon print version of record , Cover; Contents; Introduction; The Supply of Pharmaceuticals; The Demand for Pharmaceuticals; Pharmaceutical Prices; The Multinational Pharmaceutical Industry; International Price Comparisons; Timing of Pharmaceutical Approvals; Government Intervention in the Pharmaceutical Sector; Part I. The Industry; 1 The Pharmaceutical Industry; Pharmaceutical Research and Development; The Competitive Structure of the Pharmaceutical Industry; Pharmaceutical Research and Development and Prices; The Pharmaceutical Research Process; Product Liability; Conclusions; 2 The Biotechnology Industry; Background , Product Development in the Biotechnology IndustryThe Natural History of Biotechnology Firms; Case Studies of Alliances; Regulation; Case Studies of Biotechnology Firm Growth; Conclusions; 3 Other Firms in the Pharmaceutical Industry; Generic Drugs and Their Manufacturers; Outsourcing Firms; Conclusions; 4 Marketing Pharmaceuticals; Size of Marketing Effort; Does It Work?; Types of Promotion; Disguising Marketing as Research; Marketing in an Era of Managed Care; Pharmacy Benefit Managers; Direct-to-Consumer Advertising; Over-the-Counter Drugs; Joint Marketing; Disease Management , Roles of the U.S. Food and Drug Administration in MarketingFalse and Misleading Claims; Part II. The Consumer; 5 The Demand for Pharmaceuticals; How Is Demand Determined?; The Changing Structure of the Pharmaceutical Market; Conclusions; Part III. The Market; 6 Pharmaceutical Prices; The Problem of Pharmaceutical Prices; Pharmaceutical Prices over Time; Measuring Drug Prices; How Are Drug Prices Determined?; Cost Structure of Pharmaceutical Firms; Is the Pharmaceutical Industry Monopolistic?; How Drug Quality Influences Price; 7 The Worldwide Market for Pharmaceuticals , Geographic Patterns of Pharmaceutical Production and SalesPharmaceutical Research and Development: An International View; Does Government Drug Price Setting Influence R&D?; Worldwide Manufacturing and Sales; Access to Appropriate Drugs in Developing Countries; Effect of the World Trade Organization Treaty; 8 Pricing Pharmaceuticals in a World Environment; Why Do Drug Prices Vary Across Country?; Comparisons of International Drug Prices; How Do We Measure Drug Prices across Countries?; Why Drug Price Differences Persist; Policy Implications , 9 The Timing of Drug Approvals in the United States and AbroadThe Timing of Pharmaceutical Approvals and Health Policy; The Drug Approval Process in the United States; Recent Initiatives to Expedite Drug Approvals; Is There a U.S. Drug Lag?; Part IV. Intervention in the Pharmaceutical Market: Public and Private; 10 Pharmaceutical Regulation and Cost Containment by the Public Sector; Evolution of the U.S. Food and Drug Administration; Medicaid; State Cost-Containment Efforts; Medicare; 11 Regulation by the Private Sector; Cost-Containment Mechanisms; Cost Containment in Managed Care , 12 Pharmaceutical Regulation in Europe
    Additional Edition: ISBN 9780199719747
    Additional Edition: ISBN 9780195300956
    Additional Edition: Erscheint auch als Druck-Ausgabe Pharmaceutical Economics and Policy
    Language: English
    Keywords: Electronic books
    URL: Volltext  (lizenzpflichtig)
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 3
    Online Resource
    Online Resource
    Oxford : Oxford University Press, Incorporated
    UID:
    kobvindex_INT71242
    Format: 1 online resource (351 pages)
    Edition: 2nd ed.
    ISBN: 9780195300956 , 9780199719747
    Content: The pharmaceutical industry is praised as a leader in high technology innovation and the creator of products that increase both longevity and quality of life for people throughout the world. Yet the industry is also reviled for its marketing and pricing practices and even its research and development priorities. This book uses the tools of economic analysis to explore the conflicting priorities and aims of the pharmaceutical industry, from both an American and worldwide perspective. This second edition includes six new chapters on emerging topics such as the broadened role of FDA regulations, alternative drugs or "nutraceuticals," and biotechnology and other industries related to pharmaceuticals. Existing chapters are fully revised and updated to include new materials. The introduction is also updated to address the volatile pace of pharmaceutical innovation and how the pharmaceutical industry has responded to the emergence of managed care
    Note: Cover -- Contents -- Introduction -- The Supply of Pharmaceuticals -- The Demand for Pharmaceuticals -- Pharmaceutical Prices -- The Multinational Pharmaceutical Industry -- International Price Comparisons -- Timing of Pharmaceutical Approvals -- Government Intervention in the Pharmaceutical Sector -- Part I. The Industry -- 1 The Pharmaceutical Industry -- Pharmaceutical Research and Development -- The Competitive Structure of the Pharmaceutical Industry -- Pharmaceutical Research and Development and Prices -- The Pharmaceutical Research Process -- Product Liability -- Conclusions -- 2 The Biotechnology Industry -- Background -- Product Development in the Biotechnology Industry -- The Natural History of Biotechnology Firms -- Case Studies of Alliances -- Regulation -- Case Studies of Biotechnology Firm Growth -- Conclusions -- 3 Other Firms in the Pharmaceutical Industry -- Generic Drugs and Their Manufacturers -- Outsourcing Firms -- Conclusions -- 4 Marketing Pharmaceuticals -- Size of Marketing Effort -- Does It Work? -- Types of Promotion -- Disguising Marketing as Research -- Marketing in an Era of Managed Care -- Pharmacy Benefit Managers -- Direct-to-Consumer Advertising -- Over-the-Counter Drugs -- Joint Marketing -- Disease Management -- Roles of the U.S. Food and Drug Administration in Marketing -- False and Misleading Claims -- Part II. The Consumer -- 5 The Demand for Pharmaceuticals -- How Is Demand Determined? -- The Changing Structure of the Pharmaceutical Market -- Conclusions -- Part III. The Market -- 6 Pharmaceutical Prices -- The Problem of Pharmaceutical Prices -- Pharmaceutical Prices over Time -- Measuring Drug Prices -- How Are Drug Prices Determined? -- Cost Structure of Pharmaceutical Firms -- Is the Pharmaceutical Industry Monopolistic? -- How Drug Quality Influences Price -- 7 The Worldwide Market for Pharmaceuticals , Geographic Patterns of Pharmaceutical Production and Sales -- Pharmaceutical Research and Development: An International View -- Does Government Drug Price Setting Influence R& -- D? -- Worldwide Manufacturing and Sales -- Access to Appropriate Drugs in Developing Countries -- Effect of the World Trade Organization Treaty -- 8 Pricing Pharmaceuticals in a World Environment -- Why Do Drug Prices Vary Across Country? -- Comparisons of International Drug Prices -- How Do We Measure Drug Prices across Countries? -- Why Drug Price Differences Persist -- Policy Implications -- 9 The Timing of Drug Approvals in the United States and Abroad -- The Timing of Pharmaceutical Approvals and Health Policy -- The Drug Approval Process in the United States -- Recent Initiatives to Expedite Drug Approvals -- Is There a U.S. Drug Lag? -- Part IV. Intervention in the Pharmaceutical Market: Public and Private -- 10 Pharmaceutical Regulation and Cost Containment by the Public Sector -- Evolution of the U.S. Food and Drug Administration -- Medicaid -- State Cost-Containment Efforts -- Medicare -- 11 Regulation by the Private Sector -- Cost-Containment Mechanisms -- Cost Containment in Managed Care -- 12 Pharmaceutical Regulation in Europe -- The Pharmaceutical Industry in Europe -- History of Regulation in Europe -- Move Toward a Single Market -- Structure and Role of the European Medicines Evaluation Agency -- Drug Review under the European Medicines Evaluation Agency -- Current Regulatory Structure -- The Centralized Procedure for Marketing Authorization -- The Mutual-Recognition Procedure -- Performance of Europe's Centralized Drug Approval -- Rules on Labeling of Medicinal Products -- Advertising Regulations -- Pharmacovigilance -- Generic Drugs -- 13 Patent Protection -- Patent Law -- Patentability and Patent Categories -- How Are Patents Obtained? , What Protection Does a Patent Confer? -- Duration of Patent Protection -- Infringement of Patents -- International Patent Treaties -- Patent Procedures under International Conventions -- Shortcomings of the Patent System -- Patents and Societal Choice -- Social Benefits of the Patent System -- 14 Evaluating New Drugs -- Optimizing Production of Health -- Cost-Benefit Analysis -- Cost-Effectiveness Analysis -- Cost-Utility Analysis -- Policy Applications -- Interpretation and Misinterpretation of Cost-Effectiveness Studies -- 15 Complementary and Alternative Medicines -- Who Uses Complementary and Alternative Medicines? -- Manufacturers and Distributors of Complementary and Alternative Medicines -- Dietary Supplements -- Food Additives -- Medical Foods -- Concluding Remarks on Complementary and Alternative Medicines -- 16 Pharmaceuticals and Health Policy: A Look Ahead -- Structure of the Pharmaceutical Industry -- Health System Reform -- Drug Prices -- Drug Imports -- Patent Protection -- Drug Approvals -- Managed Care and Restricted Access to Pharmaceuticals -- The U.S. Food and Drug Administration -- Genetically Targeted Drugs -- Conclusions -- Index -- A -- B -- C -- D -- E -- F -- G -- H -- I -- J -- K -- L -- M -- N -- O -- P -- Q -- R -- S -- T -- U -- V -- W -- X -- Y -- Z.
    Additional Edition: Print version Schweitzer, Stuart O. Pharmaceutical Economics and Policy Oxford : Oxford University Press, Incorporated,c2006 ISBN 9780195300956
    Language: English
    Keywords: Electronic books
    URL: FULL  ((OIS Credentials Required))
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
Did you mean 9780195300598?
Did you mean 9780195300918?
Did you mean 9780195300116?
Close ⊗
This website uses cookies and the analysis tool Matomo. Further information can be found on the KOBV privacy pages